• Aucun résultat trouvé

Atrial fibrillation evolution and rhythm control strategy following left appendage closure: new insights from the prospective FLAAC registry

N/A
N/A
Info
Télécharger
Protected

Academic year: 2021

Partager "Atrial fibrillation evolution and rhythm control strategy following left appendage closure: new insights from the prospective FLAAC registry"

Copied!
10
0
0

Chargement.... (Voir le texte intégral maintenant)

Texte intégral

(1)

HAL Id: hal-03221345

https://hal.archives-ouvertes.fr/hal-03221345

Submitted on 10 May 2021

HAL is a multi-disciplinary open access archive for the deposit and dissemination of sci- entific research documents, whether they are pub- lished or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.

L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.

Atrial fibrillation evolution and rhythm control strategy following left appendage closure: new insights from the

prospective FLAAC registry

Nicolas Lellouche, Raphaele Arrouasse, Julien Ternacle, Romain Gallet, Jean-Sylvain Hermida, David Hamon, Jean-Michel Juliard, Jean-Luc Pasquie,

Tarvinder Dhanjal, Emmanuel Teiger, et al.

To cite this version:

Nicolas Lellouche, Raphaele Arrouasse, Julien Ternacle, Romain Gallet, Jean-Sylvain Hermida, et al..

Atrial fibrillation evolution and rhythm control strategy following left appendage closure: new insights from the prospective FLAAC registry. BMC Cardiovascular Disorders, BioMed Central, 2021, 21 (1), pp.227. �10.1186/s12872-021-01994-8�. �hal-03221345�

(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)

Références

Télécharger maintenant ( PDF - 10 Page - 26.09 MB )

Documents relatifs

Percutaneous Left Atrial Appendage Closure Is a Reasonable Option for Patients With Atrial Fibrillation at High Risk for Cerebrovascular Events

Percutaneous Left Atrial Appendage Closure Is a Reasonable Option for Patients With Atrial Fibril- lation at High Risk for

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation

This drug has been shown to induce an excess of mortality in some trials in other heart conditions (CAST 1991). Very few data on mortality is available for this drug when employed

Guide - Atrial Fibrillation in Adults

Start treatment with dabigatran or rivaroxaban within 2 hours before the next dose of LMWH

(1)Les chiffres manquants de Cupidon Multiplication et Division (A) Nom: Date: Remplissez tous les chiffres que Cupidon a frappé pendant qu’il s’entraînait

Remplissez tous les chiffres que Cupidon a frappé pendant qu’il

Left Atrial Appendage Electrical Isolation Reduces Atrial Fibrillation Recurrences

points (pacing locations located outside of ablated area were indicated by black stars and the pacing location within the ablated area was indicated by yellow). B) AF and

Rate versus rhythm control in atrial fibrillation

When a patient possesses factors that favour both rate control and rhythm control, patient preference, quality of life, comorbidities, side effects, and drug inter- actions

Rate versus rhythm in atrial fibrillation: And how slow do you go?

For patients with persistent atrial fibrillation (AF), how does attempting to control sinus rhythm compare with rate control, and what should the target heart rate

Anticoagulation for atrial fibrillation.

When patients present with new-onset atrial fibrillation (continuous or paroxysmal; risk of stroke is similar), 6 I now calculate their absolute risk of stroke..